DBVT · NASDAQ · Biotechnology

DBV Technologies (ADR) (DBVT)

Develops an investigational skin patch for peanut allergy using epicutaneous immunotherapy.

$13.00
After hours+0.32 (+2.48%)
At close$12.69(+4.83%)